Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hydroxychloroquine × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4 Genitourinary 3 Breast 3 Gynecologic 2 Thoracic 1 Other solid neoplasm 1 Other 1 Lymphoid 1 Head & Neck 1 Dermatologic 1

Conditions

Lymphoma, Follicular 1

Interventions

Cyclophosphamide 155 Rituximab 134 venetoclax 77 fludarabine 73 Specimen Handling 62 obinutuzumab 60 Prednisone 60 Doxorubicin 60 Vincristine 59 Magnetic Resonance Spectroscopy 51 Lenalidomide 50 zanubrutinib 47 Biopsy 46 Dexamethasone 44 Cytarabine 40 Methotrexate 37 Bendamustine Hydrochloride 33 acalabrutinib 32 Etoposide 32 fludarabine phosphate 30 blinatumomab 29 ibrutinib 28 glofitamab 25 Immunotherapy, Adoptive 25 polatuzumab vedotin 23 pirtobrutinib 23 Gemcitabine 23 pembrolizumab 20 orelabrutinib 19 Injections 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06739759 2024-12-18

OHSS

Aljazeera Hospital

Phase NA Recruiting

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡